The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis

Gut

Volumn 42, Issue 5, 1998, Pages 599-602

  Mcfarlane, I G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN ANTIBODY; ANTINUCLEAR ANTIBODY; MICROSOME ANTIBODY; SMOOTH MUSCLE ANTIBODY;

ANTIBODY DETECTION; AUTOIMMUNE HEPATITIS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEPATITIS C; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031839681     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.5.599     Document Type: Review

References (49)

1. Johnson PJ, McFarlane IG. Meeting report: International autoimmune hepatitis group. Hepatology 1993;18:998-1005.
2. Anonymous. International Working Party Report: Terminology of chronic hepatitis. Am J Gastroenterol 1995;90:181-9.
3. Donaldson PT, Doherty DG, Hayllar KM, et al. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991;13:701-6.
4. McFarlane IG. Clinical spectrum and heterogeneity of autoimmune hepatitis: an overview. In: Meyer zum Buschenfelde KH, Hoofnagle JH, Manns M, eds. Falk Symposium 70: Immunology and liver. London: Kluwer, 1993:179-92.
5. Manns M, Gerken G, Kyriatsoulis A, et al. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987;i:292-4.
6. Lunel F, Abuaf N, Frangeul L, et al. Liver kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992;16:630-6.
7. Abuaf N, Johanet C, Chretien P, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology 1992;16:892-8.
8. Czaja AJ, Manns M. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995;90:1206-11.
9. Maddrey WC. How many types of autoimmune hepatitis are there ? Gastroenterology 1993;105:1571-4.
10. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-20.
11. Czaja AJ, Cassani F, Cataleta M, et al. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci 1997;42:1688-96.
12. Leibovitch L, George J, Levi Y, et al. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol Lett 1995;48:129-32.
13. Dighiero G, Lymberi P, Monot C, et al. Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeletal proteins. Clin Exp Immunol 1990;82:52-6.
14. McFarlane IG. Autoimmunity and hepatotropic viruses. Semin Liver Dis 1991;11:223-33.
15. Takaki A, Sakaguchi K, Ogawa S, et al. Specificities and clinical significance of anti-cytoskeleton antibodies in anti-smooth muscle antibody-positive patients with chronic liver disease C. Acta Med Okayama 1994;48:143-9.
16. Toh B-H. Anti-cytoskeletal autoantibodies: diagnostic significance for liver diseases, infections and systemic autoimmune diseases. Autoimmunity 1991;11:119-25.
17. Cancado EL, Vilas-Boas LS, Abrantes-Lemos CP, et al. Heat serum inactiration as a mandatory procedure for antiactin antibody detection in cell culture. Hepatology 1996;23:1098-104.
18. Zauli D, Cassani F, Bianchi FB. Cytoskeletal antigens. In: McFarlane IG, Williams R, eds. Molecular basis of autoimmune hepatitis. Austin, Texas: RG Landes, 1996:45-58.
19. Czaja AJ, Cassani F, Cataleta M, et al. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996;24: 1068-73.
20. Manns MP. Cytoplasmic autoantigens in autoimmune hepatitis: Molecular analysis and clinical relevance. Semin Liver Dis 1991;11:205-14.
21. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992;103:1290-5.
22. Targan SR, Landers C, Vidrich A, et al. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995;108: 1159-66.
23. Treichel U, McFarlane BM, Seki T, et al. Demographics of anti-asialo-glycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenteology 1994;107:799-804.
24. Martini E, Abuaf N, Cavalli F, et al. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988; 8:1662-6.
25. Stechemesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology 1993;18:1-9.
26. Mackay IR, Tait DB. HLA associations with autoimmune type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology 1980;79:95-8.
27. Toda G, Zeniya M, Watanabe F, et al. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol 1997;26:1207-12.
28. Doherty DG, Donaldson PT, Underhill JA, et al. Allelic sequence variation in the HLA Class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994;19:609-15.
29. Manns MP, Kruger M. Immungenetics of chronic liver diseases. Gastoenterology 1994;106:1676-97.
30. Scully LJ, Toze C, Sengar DPS, et al. Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Gastroenterology 1993;104:1478-84.
31. Doherty D, Underhill JA, Donaldson PT, et al. Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis. Autoimmunity 1994;18:243-9.
32. Esteban JI, Esteban R, Viladomiou L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;ii:294-6.
33. Lenzi M, Ballardini G, Fusconi M, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990;335:258-9.
34. Yamamoto AM, Crestiel D, Homberg JC, et al. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology 1993;104:1762-7.
35. Muratori L, Lenzi M, Ma Y, et al. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 1995;37:406-12.
36. Lenzi M, Johnson PJ, McFarlane IG, et al. Antibodies to hepatitis C virus in autoimmune liver disease: Evidence for geographical heterogeneity. Lancet 1991;338:277-80.
37. Czaja AJ, Carpenter HA, Santrach PJ, et al. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol 1993;18:342-52.
38. Lindgren S, Braun HB, Michel G, et al. Absence of LKM-1 antibody reactivity in autoimmune and hepatitis C related chronic liver disease in Sweden. Scand J Gastroenterol 1997;32:175-8.
39. Cassani F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-6.
40. Bayraktar Y, Bayraktar M, Gurakar A, et al. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Hepatogastroenterology 1997;44:417-25.
41. Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987;7:1333-9.
42. Johnson PJ, McFarlane IG, McFarlane BM, et al. Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional autoantibodies. J Gastroenterol Hepatol 1990;5:244-51.
43. Czaja AJ, Hay JE, Rakela J. Clinical features and prognostic indications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc 1990;65:23-30.
44. Lenzi M, Manotti P, Muratori L, et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 1995;36:749-54.
45. Han S, Tredger M, Gregorio GV, et al. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology 1995; 21:58-62.
46. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993;105:1522-8.
47. Strettell MPJ, Donaldson PT, Thomson LJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997;112:2028-35.
48. Czaja AJ, Strettell MDJ, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997;25:317-23.
49. Kaymakoglu S, Cakaloglu Y, Demir K, et al. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? J Hepatol 1998;28:78-83.